Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Durvalumab Treatment and Real-World Survival in Stage III NSCLC: PACIFIC-R Trial Jun 30, 2023
Lung Cancer,Other Cancers,SCLC (Small Cell Lung Cancer) Maintenance Therapy with Atezolizumab+CP/ET in 1L Extensive-Stage SCLC Jun 30, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Evaluate PK, Efficacy, Safety of HER3-DXd in EGFRm NSCLC: Study 1190TiP Jun 30, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) ctDNA Levels and Response to TIS + Chemo in Advanced NSCLC Jun 30, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) ALUR Phase III Trial: Alectinib vs. Chemotherapy in ALK-Positive NSCLC After Crizotinib Jun 30, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Ripretinib vs Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial Jun 23, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Pembrolizumab Vs. Chemotherapy as First-Line Therapy in Individuals With NSCLC Jun 23, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Durvalumab after Chemoradiotherapy in Unresectable Stage III EGFR-Mutant NSCLC Jun 23, 2023
